[artículo] 
inThe American Journal of Psychiatry > Año 2019 - Vol. 176 - No.4 (Abril) . - pp. 275-286

Título :	Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression
Tipo de documento:	texto impreso
Autores:	Boadie W. Dunlop, Autor ; Devon LoParo, Autor ; Becky Kinkead, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 275-286
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Agente antidepresivo, Ansiedad, Depresión, Duloxetina, Escitalopram, Psicoterapia, Recaída
Resumen:	Adults with major depressive disorder frequently do not achieve remission with an initial treatment. Addition of psychotherapy for patients who do not achieve remission with antidepressant medication alone can target residual symptoms and protect against recurrence, but the utility of adding antidepressant medication after nonremission with cognitive-behavioral therapy (CBT) has received little study.
Link:	./index.php?lvl=notice_display&id=20503

[artículo] Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression [texto impreso] / Boadie W. Dunlop, Autor ; Devon LoParo, Autor ; Becky Kinkead, Autor . - 2019 . - pp. 275-286.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2019 - Vol. 176 - No.4 (Abril) . - pp. 275-286

Palabras clave:	Agente antidepresivo, Ansiedad, Depresión, Duloxetina, Escitalopram, Psicoterapia, Recaída
Resumen:	Adults with major depressive disorder frequently do not achieve remission with an initial treatment. Addition of psychotherapy for patients who do not achieve remission with antidepressant medication alone can target residual symptoms and protect against recurrence, but the utility of adding antidepressant medication after nonremission with cognitive-behavioral therapy (CBT) has received little study.
Link:	./index.php?lvl=notice_display&id=20503